Change in membrane permeability induced by protegrin 1: implication of disulphide bridges for pore formation

FEBS Letters
M MangoniA Chavanieu

Abstract

Protegrin 1 (PG-1) is a naturally occurring cationic antimicrobial peptide that is 18 residues long, has an aminated carboxy terminus and contains two disulphide bridges. Here, we investigated the antimicrobial activity of PG-1 and three linear analogues. Then, the membrane permeabilisation induced by these peptides was studied upon Xenopus laevis oocytes by electrophysiological methods. From the results obtained, we concluded that protegrin is able to form anion channels. Moreover, it seems clear that the presence of disulphide bridges is a prerequisite for the pore formation at the membrane level and not for the antimicrobial activity.

References

Jan 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·B L KaganR I Lehrer
Jan 1, 1987·CRC Critical Reviews in Biochemistry·N Dascal
Sep 1, 1994·Protein Science : a Publication of the Protein Society·W C WimleyS H White
Nov 2, 1993·Biochemistry·K MatsuzakiK Miyajima
Aug 1, 1995·Current Opinion in Structural Biology·S H WhiteM E Selsted
May 1, 1995·Journal of Peptide Science : an Official Publication of the European Peptide Society·S S HarwigR I Lehrer

❮ Previous
Next ❯

Citations

May 20, 1999·Biopolymers·D Andreu, L Rivas
Sep 6, 2002·Journal of Peptide Science : an Official Publication of the European Peptide Society·Dong Gun LeeKyung-Soo Hahm
Feb 22, 2011·European Biophysics Journal : EBJ·Katrin Splith, Ines Neundorf
Oct 27, 2009·Molecules and Cells·Juneyoung LeeDong Gun Lee
Oct 3, 2002·Biochemical and Biophysical Research Communications·Dong Gun LeeKyung-Soo Hahm
Mar 1, 2003·Clinics in Dermatology·Candace Thornton SpannJeffrey M Weinberg
Apr 2, 1998·Current Opinion in Immunology·T Ganz, R I Lehrer
Mar 23, 2002·Microbes and Infection·Balaji RamanathanFrank Blecha
Jul 29, 1999·The Journal of Peptide Research : Official Journal of the American Peptide Society·J F Liang, S C Kim
May 29, 2000·European Journal of Biochemistry·J P TamJ L Yang
Jun 25, 1999·The Journal of Antimicrobial Chemotherapy·P M Bennett
Mar 23, 2001·Anti-cancer Drugs·M MazelJ Temsamani
Jul 11, 2001·Critical Care Medicine·L SteinstraesserS C Wang
Apr 9, 1999·The Journal of Peptide Research : Official Journal of the American Peptide Society·H J KimP D Ryu
Dec 28, 2007·Antimicrobial Agents and Chemotherapy·Dat TranMichael E Selsted
Jan 31, 2009·PLoS Computational Biology·Dan S BolintineanuYiannis N Kaznessis
Oct 31, 2012·International Journal of Molecular Sciences·Dan S BolintineanuYiannis N Kaznessis
Sep 29, 2012·Zoological Research·Hui-Juan GuangHai-Ning Yu
Dec 18, 2013·Future Microbiology·Peter G BarlowDonald J Davidson
Oct 25, 2006·Proceedings of the National Academy of Sciences of the United States of America·Rajeswari ManiMei Hong
Jun 6, 2003·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Candace Thornton SpannBonnie Ross
Oct 16, 2004·Molecular and Cellular Neurosciences·Gunnar P H Dietz, Mathias Bähr
Jul 18, 2015·Pharmaceuticals·Biljana Mojsoska, Håvard Jenssen
Oct 16, 2010·Peptides·Dan S Bolintineanu, Yiannis N Kaznessis
Dec 25, 2007·American Journal of Reproductive Immunology : AJRI·Alexander M Cole, Amy Liese Cole
Nov 29, 2014·The Journal of Membrane Biology·Richard B Lipkin, Themis Lazaridis
Jul 6, 2014·Biochimica Et Biophysica Acta·Harini Mohanram, Surajit Bhattacharjya
Jan 16, 2010·The FEBS Journal·Sylwia Rodziewicz-MotowidłoWojciech Kamysz
Nov 4, 2000·Expert Opinion on Investigational Drugs·A J De Lucca
Dec 3, 2014·European Journal of Medicinal Chemistry·Hanjo HennemannClaudia Carl
Feb 28, 2013·Biophysical Journal·Themis LazaridisLidia Prieto
Jun 28, 2008·Biochimica Et Biophysica Acta·Andrea HickelGeorg Pabst
Jan 15, 2014·Biophysical Journal·Lidia PrietoThemis Lazaridis
Jun 23, 2009·Biochimica Et Biophysica Acta·Cana Park, Dong Gun Lee
Mar 25, 2010·Biochemical and Biophysical Research Communications·Guoqiu WuZilong Shen
May 1, 2008·Biochemical and Biophysical Research Communications·Woo Sang SungDong Gun Lee
Dec 3, 2004·Drug Discovery Today·Jamal Temsamani, Pierre Vidal

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.